RBG has reported much improved results with like-for-like sales growth driving an improvement in Adj EBITDA and Adj PBT and a significant reduction in debt. Management has flagged a return to self-funded estate expansion in FY21, once net debt/Adj EBITDA is
Interim results show good underlying progress in the period and signal that the group is on track for full-year expectations, with only a limited risk currently seen from coronavirus. We make only minor changes to forecasts associated with the adoption of IFRS16, which leaves EPS unchanged. We slightly increase our price target from 300p to 315p, based on a targeted 2021 P/E of 15.5x and EV/EBITDA of 7.8x (pre-IFRS16 basis). The shares have seen a decent run recently, placing them fairly close to our price target. Recent acquisitions mean EPS-based targets tend to undervalue the group with potential for either further acquisitive activity or unlocking value through disposals acting as a share price catalyst.